Flat-Coated Retriever Foundation and Golden Retriever Foundation Add Matching Funds for Canine Hemangiosarcoma Research

The AKC Canine Health Foundation (CHF)  has extended their matched funding opportunity for the 2018 Hemangiosarcoma Research Initiative. To date, the American Kennel Club (AKC) has matched $250,000 in donations made to CHF’s Hemangiosarcoma Research Initiative. In early August, the Golden Retriever Foundation (GRF) generously pledged to match donations up to an additional $50,000. Now the Flat-Coated Retriever Foundation (FCRF) pledges another $25,000 in matched funds. This brings CHF’s matched fundraising opportunity through the Hemangiosarcoma Research Initiative to a total of $325,000.

“By collaborating with the AKC and breed foundations such as the Golden Retriever Foundation and the Flat-Coated Retriever Foundation, we will continue to find and fund the best research to address this devastating cancer in dogs,” states Dr. Diane Brown, CHF CEO. “We are committed to finding new options for dog lovers and their canine companions affected by this disease.”

Hemangiosarcoma is a rapidly progressing cancer of the cells that line canine blood vessels. It most often affects a dog’s spleen and heart. Since 1995, CHF has invested in research to better understand the biology and progression of canine hemangiosarcoma in an effort to design new and effective approaches for prevention and treatment. CHF will continue to expand its hemangiosarcoma research funding opportunities through this initiative as part of its diverse portfolio of more than 140 currently active canine health research grants.

“The Flat-Coated Retriever Foundation is committed to a vision of future generations of sound and healthy Flat-Coats,” states Cheryl Kistner, FCRF President. “We are proud to partner with the AKC Canine Health Foundation on their Hemangiosarcoma Research Initiative to provide hope for the future good health of Flat-Coats and all dogs.”

“The Golden Retriever Foundation is committed to finding a cause and cure for hemangiosarcoma, a horrible cancer that defies early detection and lacks a remedy,” states John Cotter, GRF President. “We hope this extended match will allow individuals and organizations who have been adversely affected by hemangiosarcoma to participate in eradicating this disease.”

Since 1995 CHF has awarded more than $13 million in grants for canine cancer research. These research grants have helped scientists study cancer at the cellular level and provided breakthroughs in diagnostic and treatment options, allowing veterinarians to diagnose cancer earlier and treat it more effectively. The Hemangiosarcoma Research Initiative was started in January 2018 to focus on a better understanding of the biology and progression of this aggressive cancer. Thanks to the generous support of its donors and the collaborative efforts of the AKC, GRF, and FCRF, CHF will continue to invest in canine health research so that all dogs can live longer, healthier lives. To learn more and to join us to meet this match, visit www.akcchf.org/hemangiosarcoma.

Short URL: https://caninechronicle.com/?p=151617

Posted by chesliepickett on Sep 19 2018. Filed under Breaking News, Featured, Health & Training. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.